Clinical Trial Update: Immuno-effect of Tα1 for Stage I NSCLC [NA]

View source ↗

Summary

A clinical trial update noting ongoing recruitment for a study examining the immune effects of thymosin alpha-1 in Stage I non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Thymosin alpha-1 (thymosin alpha-1)

Snippet

Sponsor: Yousheng Mao | Conditions: Non Small Cell Lung Cancer | NA | Status: RECRUITING